PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Timolol - Glaucoma / ocular hypertension
PAD Profile : Timolol - Glaucoma / ocular hypertension
Keywords :
Intra-ocular pressure
Brand Names Include :
Tiopex, Timoptol-LA, Eysano, Timoptol,
Traffic Light Status
Status 1 of 3.
Status :
Blue
Important
Formulations :
- Eye drops
Important Information :
0.25% and 0.5% eye drops. Prescribe generically. Initiation by specialist team before transfer of prescribing to primary care.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 3.
Status :
Blue
Important
Formulations :
- Eye gel
Important Information :
0.25% and 0.5% gel-forming solution (Timoptol-LA)
Initiation by specialist team before transfer of prescribing to primary care.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 3 of 3.
Status :
Blue
Important
Formulations :
- Eye drops (preservative free, unit dose)
Important Information :
0.1% (1mg/g) preservative free eye gel. Once daily use.
Initiation by specialist team before transfer of prescribing to primary care.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
- Latanoprost
- Bimatoprost
- Dorzolamide and timolol
- Brinzolamide
- Brimonidine tartrate
- Dorzolamide
- Latanoprost and timolol
- Acetazolamide
- Timolol and bimatoprost
- Timolol and brimonidine
- Brinzolamide/brimonidine
- Brinzolamide and timolol
- Tafluprost
- Travoprost
- Timolol and travoprost
- Pilocarpine hydrochloride
- Betaxolol
- Levobunolol hydrochloride
- Apraclonidine
Other Indications
No indications returned.
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
02 November 2016
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The PCN recommends the prescribing of timolol maleate 1mg/g preservative free eye gel (Tiopex) as an alternative treatment option*, for the reduction of elevated intraocular pressure in patients with ocular hypertension or glaucoma where a preservative free preparation is indicated. Tiopex will be considered Blue (no information sheet) on the traffic light system. *Once daily formulation which may be a more cost effective treatment option for some patients as an alternative to timolol preservative free single dose vials.
Associated BNF Codes
11. Eye
11.06.00. Treatment of glaucoma